Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma

Affiliations

Comment

Nithin S G et al. JAMA Oncol. 2022.

. 2022 Aug 1;8(8):1224.

doi: 10.1001/jamaoncol.2022.2065.

¹ Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

No abstract available

Comment in

Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma-Reply.
Liu GY, Li WZ, Xiang YQ. Liu GY, et al. JAMA Oncol. 2022 Aug 1;8(8):1224-1225. doi: 10.1001/jamaoncol.2022.2068. JAMA Oncol. 2022. PMID: 35771532 No abstract available.

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
Liu GY, Li WZ, Wang DS, Liang H, Lv X, Ye YF, Zhao C, Ke LR, Lv SH, Lu N, Bei WX, Cai ZC, Chen X, Liang CX, Guo X, Xia WX, Xiang YQ. Liu GY, et al. JAMA Oncol. 2022 Apr 1;8(4):553-561. doi: 10.1001/jamaoncol.2021.7366. JAMA Oncol. 2022. PMID: 35175316 Free PMC article. Clinical Trial.